Robert Koch Foundation

What Robert Koch Foundation does

The Robert Koch-Institut (RKI), referred to as "Robert Koch Foundation" in the input data, is Germany's central federal institution for disease surveillance and public health research, operating as an upper federal authority under the Federal Ministry of Health (Bundesministerium für Gesundheit) since its founding in 1891. It serves the German federal government, state and local public health authorities (Öffentlicher Gesundheitsdienst), international organizations including WHO and ECDC, and indirectly the entire German population through its statutory mandate to protect public health under the Infection Protection Act (IfSG), the BGA-Nachfolgegesetz, and the International Health Regulations (2005).

RKI's operational core comprises epidemiological surveillance systems, specialized laboratory diagnostics, and population health monitoring. It operates National Reference Centers and consultant laboratories for pathogens including staphylococci, enterococci, measles, mumps, and rubella, and runs an S4 high-security laboratory constructed in 2015 at its Seestraße site in Berlin-Wedding. It established the Center for Artificial Intelligence in Public Health Research (ZKI-PH) near Technische Hochschule Wildau in 2021 and launched the Panel 'Gesundheit in Deutschland' in 2024 for continuous population health data. Scientific outputs include the weekly Epidemiologisches Bulletin, Journal of Health Monitoring, RKI-Ratgeber infectious disease guides, and the edoc open-access institutional repository. The institute is currently executing its RKI 2035 strategy, GHPP Phase 3 (2026-2028) covering 19 projects, and a planned new office and laboratory building from 2026.

RKI is funded primarily through federal budget allocations from the Federal Ministry of Health, supplemented by research project grants from DFG, EU, and WHO sources. It operates five sites across Germany — three in Berlin-Wedding (Nordufer, Seestraße, Gerichtstraße, with the latter opened end of 2024), plus Wernigerode and Wildau — and employs approximately 1,500 staff from 90 professions and 50 nations. RKI does not charge for its public health services; no commercial pricing is disclosed because all services are publicly funded through taxation. GTM motion is government-relations led rather than commercial sales, with distribution occurring through institutional channels, open-access publications, and the public health service network.

Name

Robert Koch Foundation

Legal name

Robert Koch-Institut

Website

https://rki.de

Company type

Private

Founded year

1891

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Germany's federal public health institute conducting infectious disease surveillance, population health monitoring, and laboratory diagnostics for the Federal Ministry of Health, public health authorities, WHO, ECDC, and the German population, funded by federal budget allocations.

Ownership category

akta.pro rank

Product category

Government Public Health Institute

NAICS

Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511), Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)

SIC

Services-Medical Laboratories (8071), Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

National Public Health Reference Laboratories (HLAJAIAA)

akta.pro secondary industries

Syndromic & Event-Based Surveillance (HLAJANAC), Disease-Specific Reference Laboratory Networks (e.g., TB, HIV, Influenza) (HLAJAIAD), Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms (HLACAOAM), Public Health Laboratories & Diagnostic Oversight (BPAIAJAF), Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels) (HLAAALAC)

Keywords

• Public health institute
• Disease surveillance
• Epidemiological research
• Infectious disease monitoring
• Population health research

Headquarters

HQ city

Berlin

HQ country

Germany

HQ region

Europe

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Revenue model

1. Government Funding: RKI is primarily financed by public funds through the Federal Ministry of Health (Bundesministerium für Gesundheit). As an upper federal authority in the business area of the Federal Ministry of Health, it receives government budget allocations for its operations and research activities.
2. Research Project Funding: Additional funding from research projects including DFG (Deutsche Forschungsgemeinschaft) grants for special research areas, EU projects, and international collaborations through WHO and other organizations.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

The Robert Koch Institute (RKI) operates as Germany's central federal institution for infection protection, delivering epidemiological surveillance, laboratory diagnostics, and population health monitoring. It provides disease surveillance data, scientific recommendations, and policy advice to federal and state health authorities, while operating National Reference Centers and maintaining specialized high-security laboratories. As an upper federal authority under the Federal Ministry of Health, RKI produces open-access publications, population health panels, and reference guidance for medical professionals and the public.

Product overview

The Robert Koch Institute (RKI) is Germany's federal public health institute offering a portfolio of surveillance platforms, scientific publications, and reference laboratory services. Its core products include the weekly Epidemiologisches Bulletin and the Journal of Health Monitoring for disseminating epidemiological data; the 'Gesundheit in Deutschland' panel for population health surveillance; and the edoc institutional repository for open access research publications. Additional offerings include disease-specific RKI-Ratgeber guides and a network of National Reference Centres providing diagnostic expertise.

Differentiator

Problem solved

Functional benefit

Products and services

• Epidemiologisches Bulletin
• Journal of Health Monitoring
• Panel 'Gesundheit in Deutschland'
• edoc - Open Access Publication Server
• RKI-Ratgeber
• National Reference Centres and Consultant Laboratories

Quantifiable outcome

• For 2025, 3,152 confirmed HIV new diagnoses reported to RKI
• +2 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Nine partnerships are on record, tiered core and major.

• World Health Organization (WHO)coreStrategic or Co-development Partner · 1 January 2026RKI serves as WHO Collaborating Centre for antibiotic resistance, antibiotic consumption, and nosocomial infections. The institute fulfills tasks for WHO and coordinates international research projects under WHO frameworks. RKI provides epidemiological data and expertise for global health emergency response.
• European Centre for Disease Prevention and Control (ECDC)coreStrategic or Co-development Partner · 1 January 2026RKI operates EU Reference Laboratories for Public Health, contributing to European disease surveillance networks and coordinated response to health threats.
• Deutsche Forschungsgemeinschaft (DFG)majorStrategic or Co-development Partner · 1 January 2026DFG funds special research areas including 'VirusREvolution' (Decoding tools for virus research) where RKI collaborates with Ludwig-Maximilians-Universität München on tools for analyzing functional sequence elements in viral genomes.
• Federal Ministry of Health (Bundesministerium für Gesundheit)coreStrategic or Co-development Partner · 1 January 2026RKI is an upper federal authority in the business area of the Federal Ministry of Health, which provides primary funding and strategic direction. The ministry established the Global Health Protection Programme (GHPP) in 2016.
• Global Health Protection Programme (GHPP) Partner CountriesmajorStrategic or Co-development Partner · 1 January 2026Through GHPP Phase 3 (2026-2028), RKI collaborates with 19 projects across multiple partner countries including Côte d'Ivoire (PAcCIR, PASQUALE 4-S), Nigeria (COPE II, STRAIN), Madagascar (STRAIN), Sri Lanka (IDEA-ALL), and others for capacity building in outbreak management, surveillance, laboratory diagnostics, and hygiene measures.
• Helmholtz-Zentrum für Infektionsforschung (HZI)majorStrategic or Co-development Partner · 1 January 2026Collaboration on pandemic preparedness initiatives including PREPARE-EU workshop 'Translating European Expertise to Pandemic Preparedness'. RKI researchers participate in joint activities with HZI and German Center for Infection Research (DZIF).
• Bernhard-Nocht-Institut für Tropenmedizin (BNITM)majorStrategic or Co-development Partner · 1 January 2026Joint organization of mobile laboratory training in Côte d'Ivoire with BNITM and Helmholtz Institute for One Health (HIOH) for outbreak response capacity building.
• Ludwig-Maximilians-Universität München (LMU)majorStrategic or Co-development Partner · 1 January 2026Collaboration in DFG-funded Sonderforschungsbereich 'VirusREvolution' for developing tools to analyze functional sequence elements in virus genomes and understand viral evolution.
• Technische Hochschule WildaumajorStrategic or Co-development Partner · 1 January 2021Partnership for the Center for Artificial Intelligence in Public Health Research (ZKI-PH), utilizing TH Wildau's expertise in applied biosciences and informatics to strengthen public health through new methods.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Public Health Agency of Sweden (Folkhälsomyndigheten): Sweden's Folkhälsomyndigheten operates as a direct ECDC-coordinating national public health institute with parallel infectious disease surveillance, microbiology reference work, and population-health monitoring functions. Comparable in scope, scale, and mandate to RKI.
• Norwegian Institute of Public Health (FHI): FHI is Norway's national public health institute covering infectious disease surveillance, reference microbiology, environmental health, and population health research — directly overlapping RKI's portfolio with similar scale and statutory remit.
• UK Health Security Agency (UKHSA): UKHSA is the UK's specialist agency for infectious disease preparedness and response, formed from Public Health England in 2021. It mirrors RKI's scope across surveillance, reference labs, and outbreak response, at slightly larger scale and on the WHO collaborating centre network.
• Istituto Superiore di Sanità (ISS): Italy's national institute of health — performs research, surveillance, and reference laboratory functions in infectious and chronic disease under the Italian Ministry of Health, comparable in scope and institutional role to RKI in Germany.
• Robert Koch-Institut RIVM (National Institute for Public Health and the Environment, Netherlands): RIVM performs nearly identical functions for the Netherlands — infectious disease surveillance, reference laboratory work, population health monitoring, and government advisory. RIVM is the closest geographically and structurally comparable peer to RKI.
• European Centre for Disease Prevention and Control (ECDC): ECDC is the EU-level agency coordinating disease surveillance and reference laboratory services across member states, directly overlapping RKI's infectious-disease surveillance, ECDC reference-lab work, and outbreak response mandates. RKI formally participates as an EU reference laboratory and coordinates joint outputs with ECDC.
• Santé publique France: France's national public health agency performs the same triple role of disease surveillance, epidemiology, and health monitoring that RKI does, with comparable statutory authority under French public health law. Directly comparable on mandate, scope, and outputs.

Broad incumbents

• U.S. Centers for Disease Control and Prevention (CDC): The U.S. CDC is a much larger, broader federal public health agency with a comparable mandate — infectious disease surveillance, reference labs, outbreak response, and population health — but at significantly greater scale and global brand presence than RKI.
• World Health Organization (WHO): WHO is the global public health body that RKI directly collaborates with as a Collaborating Centre for antibiotic resistance and infectious diseases. While not a direct competitor, WHO is the broader international counterpart setting frameworks RKI implements.

Regional players

• Bernhard-Nocht-Institut für Tropenmedizin (BNITM): BNITM is Germany's specialist institute for tropical medicine, jointly organizing mobile laboratory training in Côte d'Ivoire with RKI under GHPP. It is an adjacent German peer with overlapping tropical pathogen reference-lab and outbreak-response functions.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/rki_de
• LinkedInlinkedin.com/company/robert-koch-institute

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Robert Koch Foundation